Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Nolfe

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
La Clinica Terapeutica|January 1, 1993
[An evaluation of the therapeutic activity and tolerance of ST-679 in patients with osteoarthritis at different sites. A controlled double-blind study vs tolmetin]M Lingetti, M Ciarimboli, F A Porfido, et al.
Drugs Under Experimental and Clinical Research|May 25, 1999
Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trialA Dal Lago, D De Martini, R Flore, et al.
International Journal of Obesity (2005)|December 2, 2009
Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistanceJ M Moreno-Navarrete, M Manco, J Ibáñez, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
La Clinica Terapeutica|January 1, 1993
[An evaluation of the therapeutic activity and tolerance of ST-679 in patients with osteoarthritis at different sites. A controlled double-blind study vs tolmetin]M Lingetti, M Ciarimboli, F A Porfido, et al.
Drugs Under Experimental and Clinical Research|May 25, 1999
Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trialA Dal Lago, D De Martini, R Flore, et al.
International Journal of Obesity (2005)|December 2, 2009
Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistanceJ M Moreno-Navarrete, M Manco, J Ibáñez, et al.
Pageof 6